RHT
$21M—
Resonance Health Limited
Medical Technology
MedTech company specialising in non-invasive MRI-based liver and heart iron assessment and clinical trial imaging services
Cash data from Dec 2025 4CFigures from ASX filings · not financial advice
[ VITALS ]
Cash on Hand
$2.7M
Dec 2025 4C
Runway
—Based on Dec 2025 4C
Market Cap
$21M
Burn Rate
—
Dec 2025 4C
Shares Outstanding
477M
Pipeline Assets
3
Latest Insight(1)
31 Mar 2026Insider TradeChange of Director's Interest Notice - Simon Panton
1 transaction·+$106k net buyPanton: bought $106k
3M Price
RHT.ASX$0.044+0.0% 3M
Low $0.036High $0.048
Pipeline Assets (3)
FerriScan / FerriSmartliver iron overload
ApprovedHepaFatSmartliver fat assessment (NAFLD/MASLD)
ApprovedLiverSmartmulti-parametric liver assessment
ApprovedDiscovery
Preclinical
Ph 1
Ph 1/2
Ph 2
Ph 2/3
Ph 3
NDA
Capital Raises & Buybacks
show_chart
No capital raise or buyback data
Director Transactions
1 transactionLast 90dNet Buy
Buys1+1 vs prior
Sells0
Buy Value$106k
$106,0002026-03-27
Director Options & Rights
Director
Outstanding
Ex. Price
Expiry
No option data entered yet
Competitive Landscape
5 competitor trialsPhase 2+ · Non-ASX
Liver Fat Assessment (Nafld/Masld)5 active trials
2 Ph33 Ph2
Competitor trials from ClinicalTrials.gov (Phase 2+ historical, Phase 3+ refreshed weekly, active/recruiting, non-ASX sponsors). Approved drugs from OpenFDA (NDA/BLA only). Updated weekly via fetch_competitors.py.
Catalysts (1)
Sun Pharma CRO contract milestones ($13.775M, 24-month)
UpcomingConfirmedarrow_upwardHigh31 Dec 2026
| Event | Type | Confidence | Impact | Date | Status |
|---|---|---|---|---|---|
| Sun Pharma CRO contract milestones ($13.775M, 24-month) | commercial milestone | Confirmed | arrow_upwardHigh | 31 Dec 2026 | Upcoming |
Delivery Consistency Index
Historical delivery and spending consistency — data is limited for recently added companies.
Track record will build as data accumulates — we need completed catalysts with original guidance dates, or at least two quarterly 4Cs, before scoring kicks in.
Clinical Trials(1)
No active trials
Announcements(5)
person
Insider Tradeauto_awesome
Change of Director's Interest Notice - Simon Panton31 Mar 2026
expand_more4KB